Medication info
Lactamox Tablets (Amoxicillin Hydrate, Clavulanate Potassium)

Lactamox Tablets (Amoxicillin Hydrate, Clavulanate Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›250mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Aprogen Pharmaceuticals Co., Ltd.
Appearance
Oval-shaped film-coated tablets, white to nearly white.
Packaging
100 tablets (10 tablets/PTPX10)
Approval status
Active

MFDS item code 199800953 · Notified 1998.01.06 · Insurance code 645200440

Summary

Main use
Treatment of respiratory infections, genitourinary infections, and other infections (skin, bone, dental, etc.)
Who takes it
Adults · Children
Adult dose
The dose of this medicine should be determined based on the patient’s age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dose adjustments are based on the maximum recommended dose of amoxicillin. No dose adjustment is required in patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Aprogen Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of respiratory infections, genitourinary infections, and other infections (skin, bone, dental, etc.)

  • Acute bronchitis
  • chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
View approved original text

This medication is effectively used for various types of bacterial infections. It treats respiratory infections such as acute and chronic bronchitis, pneumonia, and is effective for urogenital infections such as cystitis, urethritis, and pyelonephritis. Additionally, it is used for the treatment of pelvic infections and sexually transmitted diseases like gonorrhea, as well as skin and soft tissue infections such as abscesses, cellulitis, and wound infections. It is also utilized for osteomyelitis and dental infections to improve the condition of the infected areas. This drug is widely used for the treatment of bacterial infections in multiple locations.

How to take

Adult dose

The dose of this medicine should be determined based on the patient’s age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. Adults: Dose adjustments are based on the maximum recommended dose of amoxicillin. No dose adjustment is required in patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Precautions

This drug is a beta-lactam antibiotic belonging to the penicillin class. It should not be administered to patients who have had hypersensitivity reactions to the components or other beta-lactam antibiotics. Such hypersensitivity reactions may include anaphylaxis, severe skin reactions, and shock. Caution is necessary for patients with viral infections such as infectious mononucleosis or lymphocytic leukemia, as the risk of rash may be increased. Furthermore, patients with a history of liver dysfunction or jaundice related to this drug or penicillin class medications should avoid its use due to the risk of recurrence. For patients with impaired liver or kidney functions, the drug concentration may increase, hence dosing intervals should be adjusted or the drug should be used cautiously. Care should also be taken with patients who have allergies, severe gastrointestinal diseases with vomiting or diarrhea, the elderly, or those in poor general condition. This medication may cause gastrointestinal side effects such as diarrhea, abdominal pain, and vomiting, and rarely may lead to severe colitis or acute pancreatitis, so any unusual symptoms should be promptly discussed with healthcare providers. Abnormal liver function has also been reported, particularly in elderly patients over 60 years or males, so regular liver function tests are recommended. Skin rashes, urticaria, and in severe cases, serious skin reactions like Stevens-Johnson syndrome may occur, and drug administration should be stopped immediately if such symptoms arise. Rare instances of blood dyscrasia such as leukopenia, thrombocytopenia, and hemolytic anemia have been reported, necessitating regular blood tests. Central nervous system side effects may also occur, such as anxiety, drowsiness, and seizures, hence symptoms should be reported to medical staff. There may be a sudden deterioration in kidney function; therefore, regular kidney function tests should be conducted and administration should be discontinued upon any abnormalities. The development of resistant bacteria is possible with prolonged use, so the drug should only be used for the minimum necessary duration, and more caution is needed if used for more than 14 days. This drug may interact with other medications, particularly anticoagulants, anti-inflammatory drugs, and other antibiotics, so consultation with a specialist is advised. Women who are pregnant or breastfeeding should carefully consider the benefits and risks of using this medication, especially avoiding administration during the first three months of pregnancy. The use of this medication in children under the age of 12 or weighing less than 40 kg is not recommended due to limited experience. In elderly patients, there is an increased likelihood of adverse reactions due to decreased bodily functions, so dosing and intervals should be adjusted while monitoring their condition. Regular tests for liver function, kidney function, and blood tests should be conducted during treatment to detect abnormal signs as early as possible. In case of overdose, gastrointestinal symptoms or central nervous system symptoms may appear, and immediate medical attention is required. This drug should be stored in a sealed container to prevent moisture, and should be kept at a cool temperature between 1°C to 25°C. This helps maintain the drug's effectiveness and prevents degradation.

Side effects

  • Diarrhea
  • pseudomembranous colitis
  • indigestion
  • stomatitis
  • gastritis
  • glossitis
  • black hairy tongue
  • nausea
  • vomiting
  • loss of appetite
Show 75 more
  • abdominal pain
  • abdominal bloating
  • constipation
  • colonic pain
  • hyperacidity
  • clay-colored stools
  • dry mouth
  • acute pancreatitis
  • candidiasis
  • antibiotic-induced colitis
  • hematochezia
  • itching
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • vesicular exfoliative dermatitis
  • acute generalized pustular psoriasis
  • eosinophilia
  • angioedema
  • anaphylaxis
  • serum sickness syndrome
  • hypersensitivity vasculitis
  • bronchospasm
  • dyspnea
  • laryngeal edema
  • anaphylactic shock
  • leukopenia
  • thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • vaginal itching
  • vaginal burning
  • increased secretion
  • anxiety
  • agitation
  • behavioral changes
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • convulsions
  • antispasmodic
  • fever
  • altered consciousness
  • aseptic meningitis
  • acute renal failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • symptoms of vitamin K deficiency
  • symptoms of vitamin B deficiency
  • linear IgA disease
  • dysgeusia
  • lethargy
  • dermatitis
  • oral edema
  • gastric pain
  • fluid and electrolyte imbalance
  • rash
  • hyperactivity
  • drowsiness
  • renal failure
  • interstitial cerebral convulsion
  • hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent moisture and should be kept at a cool temperature between 1°C and 25°C. This will maintain the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Oval-shaped film-coated tablets, white to nearly white.

Package unit

100 tablets (10 tablets/PTPX10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.